{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:23:36Z","timestamp":1790796216171,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.cll.2007.05.006","type":"journal-article","created":{"date-parts":[[2007,7,21]],"date-time":"2007-07-21T11:23:52Z","timestamp":1185017032000},"page":"551-575","source":"Crossref","is-referenced-by-count":68,"title":["Myeloid Malignancies: Myelodysplastic Syndromes, Myeloproliferative Disorders, and Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"27","author":[{"given":"Brent L.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2007.05.006_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-679X(04)75023-2","article-title":"Multicolor immunophenotyping: human immune system hematopoiesis","volume":"75","author":"Wood","year":"2004","journal-title":"Methods Cell Biol"},{"issue":"9","key":"10.1016\/j.cll.2007.05.006_bib2","first-page":"657","article-title":"Flow cytometric analysis of human bone marrow. III. Neutrophil maturation","volume":"4","author":"Terstappen","year":"1990","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.cll.2007.05.006_bib3","first-page":"229","article-title":"Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry","volume":"2","author":"Terstappen","year":"1990","journal-title":"Anal Cell Pathol"},{"issue":"2","key":"10.1016\/j.cll.2007.05.006_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jlb.48.2.138","article-title":"Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells","volume":"48","author":"Terstappen","year":"1990","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.cll.2007.05.006_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1182\/blood.V69.1.255.255","article-title":"Flow cytometric analysis of human bone marrow: I.\u00a0Normal erythroid development","volume":"69","author":"Loken","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.cll.2007.05.006_bib6","series-title":"The flow cytometric evaluation of hematopoietic neoplasia in Henry's clinical diagnosis and management by laboratory methods","author":"Wood","year":"2006"},{"issue":"9","key":"10.1016\/j.cll.2007.05.006_bib7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.5858\/2003-127-1140-UCFCTI","article-title":"Using 4-color flow cytometry to identify abnormal myeloid populations","volume":"127","author":"Kussick","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"18","key":"10.1016\/j.cll.2007.05.006_bib8","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1073\/pnas.172384399","article-title":"Prospective isolation of human clonogenic common myeloid progenitors","volume":"99","author":"Manz","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.cll.2007.05.006_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1309\/T903Y1FY5WKK9EEY","article-title":"Flow cytometric analysis of different CD14 epitopes can help identify immature monocytic populations","volume":"124","author":"Yang","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2007.05.006_bib10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+ CD16+ blood monocytes: their role in infection and inflammation","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"13","key":"10.1016\/j.cll.2007.05.006_bib11","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2001-11-0097","article-title":"Characterization of human blood dendritic cell subsets","volume":"100","author":"MacDonald","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2007.05.006_bib12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1182\/blood.V98.4.979","article-title":"Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome","volume":"98","author":"Stetler-Stevenson","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2007.05.006_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2007.05.006_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1309\/6PBP78G4FBA1FDG6","article-title":"Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia","volume":"124","author":"Kussick","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.cll.2007.05.006_bib15","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1309\/CAUT52HJ535P9UG2","article-title":"Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders","volume":"120","author":"Kussick","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.cll.2007.05.006_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.5858\/2006-130-680-CACFCI","article-title":"9-Color and 10-color flow cytometry in the clinical laboratory","volume":"130","author":"Wood","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cll.2007.05.006_bib17","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of hematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"issue":"5","key":"10.1016\/j.cll.2007.05.006_bib18","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/ajcp\/100.5.534","article-title":"Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis","volume":"100","author":"Borowitz","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2007.05.006_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1749-6632.1993.tb38783.x","article-title":"CD45 gating for routine flow cytometric analysis of human bone marrow specimens","volume":"677","author":"Stelzer","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.cll.2007.05.006_bib20","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1182\/blood-2002-01-0222","article-title":"Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome","volume":"100","author":"Ogata","year":"2002","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cll.2007.05.006_bib21","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1182\/blood-2005-04-1543","article-title":"Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome","volume":"106","author":"Sternberg","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2007.05.006_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cyto.b.20041","article-title":"Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes","volume":"64","author":"Cherian","year":"2005","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"10.1016\/j.cll.2007.05.006_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1309\/M9FQMQGF66167N2X","article-title":"Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders","volume":"125","author":"Agis","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.cll.2007.05.006_bib24","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1182\/blood-2002-03-0947","article-title":"Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia","volume":"101","author":"Matsushima","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cll.2007.05.006_bib25","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2003-04-1150","article-title":"Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib","volume":"102","author":"Wilkinson","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2007.05.006_bib26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2006.06038.x","article-title":"Eosinophilia: secondary, clonal and idiopathic","volume":"133","author":"Tefferi","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.cll.2007.05.006_bib27","first-page":"70","article-title":"Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis","volume":"6","author":"Terstappen","year":"1992","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.cll.2007.05.006_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ajcp\/109.2.211","article-title":"The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities","volume":"109","author":"Khalidi","year":"1998","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.cll.2007.05.006_bib29","first-page":"993","article-title":"Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells","volume":"6","author":"Terstappen","year":"1992","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.cll.2007.05.006_bib30","first-page":"531","article-title":"Chronic versus acute myelogenous leukemia: a question of self-renewal","volume":"6","author":"Jamieson","year":"2004","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.cll.2007.05.006_bib31","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-05-0468","article-title":"High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival","volume":"11","author":"van Rhenen","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.cll.2007.05.006_bib32","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2005-12-4916","article-title":"Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes","volume":"108","author":"Ogata","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cll.2007.05.006_bib33","first-page":"1104","article-title":"Surface marker abnormalities in myelodysplastic syndromes","volume":"83","author":"Elghetany","year":"1998","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.cll.2007.05.006_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.V99.1.391","article-title":"Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome","volume":"99","author":"Elghetany","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cll.2007.05.006_bib35","first-page":"292","article-title":"Abnormal patterns of expression of CD16 (FcR-III) and CD11b (CRIII) in the bone marrow of patients with myelodysplastic syndrome","volume":"3","author":"Bowen","year":"1997","journal-title":"Laboratory Hematolology"},{"issue":"8","key":"10.1016\/j.cll.2007.05.006_bib36","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.5858\/2000-124-1152-DCPMGI","article-title":"Decreased CD10-positive mature granulocytes in bone marrow from patients with myelodysplastic syndrome","volume":"124","author":"Chang","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.cll.2007.05.006_bib37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.5858\/2006-130-654-NCIAII","article-title":"Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients","volume":"130","author":"Davis","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.cll.2007.05.006_bib38","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/ajcp\/107.6.653","article-title":"Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes","volume":"107","author":"Mann","year":"1997","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.cll.2007.05.006_bib39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1537-2995.1998.38798346635.x","article-title":"Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor","volume":"38","author":"Stroncek","year":"1998","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.cll.2007.05.006_bib40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1600-0609.1998.tb01098.x","article-title":"Flow cytometric identification of myeloid disorders by asynchronous expression of the CD14 and CD66 antigens","volume":"61","author":"Hansen","year":"1998","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.cll.2007.05.006_bib41","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.leu.2403680","article-title":"Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome","volume":"19","author":"Malcovati","year":"2005","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.cll.2007.05.006_bib42","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.leu.2404142","article-title":"Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome","volume":"20","author":"Della Porta","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.cll.2007.05.006_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000203669","article-title":"The expression of transferrin receptors on erythroblasts in anaemia of chronic disease, myelodysplastic syndromes and iron deficiency","volume":"97","author":"Kuiper-Kramer","year":"1997","journal-title":"Acta Haematol"},{"issue":"1","key":"10.1016\/j.cll.2007.05.006_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2004.05156.x","article-title":"Multiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia","volume":"127","author":"Leinoe","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.cll.2007.05.006_bib45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-0038-1653807","article-title":"Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder","volume":"73","author":"Handa","year":"1995","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.cll.2007.05.006_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1365-2141.2000.02030.x","article-title":"Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders","volume":"110","author":"Jensen","year":"2000","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.cll.2007.05.006_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0049-3848(99)00095-X","article-title":"Increased platelet surface expression of P-selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia","volume":"96","author":"Griesshammer","year":"1999","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.cll.2007.05.006_bib48","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.2000.02430.x","article-title":"The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia","volume":"111","author":"Li","year":"2000","journal-title":"Br J Haematol"},{"issue":"5A","key":"10.1016\/j.cll.2007.05.006_bib49","first-page":"3347","article-title":"Endomitotic index of megakaryocytes measured by flow cytometry helps to diagnose hematological disorders with abnormal platelet counts","volume":"18","author":"Baatout","year":"1998","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.cll.2007.05.006_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0609.1996.tb00717.x","article-title":"Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis","volume":"56","author":"Jacobsson","year":"1996","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.cll.2007.05.006_bib51","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/sj.leu.2400648","article-title":"CD34+ megakaryoblastic leukaemic cells are CD38-, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7?","volume":"11","author":"Helleberg","year":"1997","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.cll.2007.05.006_bib52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1309\/XREF-C9T2-6U0A-4EDT","article-title":"Transient myeloproliferative disorder and acute myeloid leukemia in down syndrome. An immunophenotypic analysis","volume":"116","author":"Karandikar","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"1\u20132","key":"10.1016\/j.cll.2007.05.006_bib53","first-page":"122","article-title":"Megakaryoblastic termination of myeloproliferative disorders","volume":"40","author":"Amin","year":"1992","journal-title":"Henry Ford Hosp Med J"},{"issue":"9","key":"10.1016\/j.cll.2007.05.006_bib54","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood.V79.9.2399.2399","article-title":"False-positive flow cytometric platelet glycoprotein IIb\/IIIa expression in myeloid leukemias secondary to platelet adherence to blasts","volume":"79","author":"Betz","year":"1992","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cll.2007.05.006_bib55","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood-2002-01-0230","article-title":"Immunophenotypic clustering of myelodysplastic syndromes","volume":"100","author":"Maynadie","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2007.05.006_bib56","first-page":"402","article-title":"Immunophenotypic analysis of myelodysplastic syndromes","volume":"88","author":"Del Canizo","year":"2003","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.cll.2007.05.006_bib57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.thj.6200370","article-title":"Impact of immunophenotype on prognosis of patients with myelodysplastic syndromes. Its value in patients without karyotypic abnormalities","volume":"5","author":"Arroyo","year":"2004","journal-title":"Hematol J"},{"issue":"1","key":"10.1016\/j.cll.2007.05.006_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cyto.a.10104","article-title":"Immunophenotyping of acute leukemias and myelodysplastic syndromes","volume":"58","author":"Orfao","year":"2004","journal-title":"Cytometry A"},{"issue":"2","key":"10.1016\/j.cll.2007.05.006_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0037-1963(01)90046-0","article-title":"Flow cytometry in the diagnosis of acute leukemia","volume":"38","author":"Weir","year":"2001","journal-title":"Semin Hematol"},{"issue":"6","key":"10.1016\/j.cll.2007.05.006_bib60","first-page":"993","article-title":"Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies","volume":"9","author":"Macedo","year":"1995","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.cll.2007.05.006_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01700374","article-title":"Characterization of aberrant phenotypes in acute myeloblastic leukemia","volume":"70","author":"Macedo","year":"1995","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.cll.2007.05.006_bib62","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood.V84.4.1220.1220","article-title":"Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group","volume":"84","author":"Bradstock","year":"1994","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cll.2007.05.006_bib63","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1182\/blood.V81.11.3083.3083","article-title":"Expression of unusual immunophenotype combinations in acute myelogenous leukemia","volume":"81","author":"Reading","year":"1993","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cll.2007.05.006_bib64","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.cll.2007.05.006_bib65","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/sj.leu.2402504","article-title":"Antigen expression patterns reflecting genotype of acute leukemias","volume":"16","author":"Hrusak","year":"2002","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.cll.2007.05.006_bib66","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood.V87.3.1162.bloodjournal8731162","article-title":"Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21)","volume":"87","author":"Porwit-MacDonald","year":"1996","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2007.05.006_bib67","first-page":"405","article-title":"The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements","volume":"84","author":"Orfao","year":"1999","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.cll.2007.05.006_bib68","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ajcp\/110.6.797","article-title":"The usefulness of CD64, other monocyte-associated antigens, and CD45 gating in the subclassification of acute myeloid leukemias with monocytic differentiation","volume":"110","author":"Krasinskas","year":"1998","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.cll.2007.05.006_bib69","first-page":"646","article-title":"Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow","volume":"88","author":"Kern","year":"2003","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.cll.2007.05.006_bib70","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood.V98.6.1746","article-title":"Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification","volume":"98","author":"San Miguel","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2007.05.006_bib71","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.2003.04610.x","article-title":"Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia","volume":"123","author":"Coustan-Smith","year":"2003","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.cll.2007.05.006_bib72","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V96.12.3948","article-title":"Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia","volume":"96","author":"Venditti","year":"2000","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cll.2007.05.006_bib73","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/sj.leu.2403138","article-title":"Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation","volume":"17","author":"Venditti","year":"2003","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.cll.2007.05.006_bib74","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.leu.2404313","article-title":"The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia","volume":"20","author":"Buccisano","year":"2006","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.cll.2007.05.006_bib75","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1182\/blood-2004-03-1036","article-title":"Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia","volume":"104","author":"Kern","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cll.2007.05.006_bib76","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/sj.leu.2403405","article-title":"MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia","volume":"18","author":"Feller","year":"2004","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.cll.2007.05.006_bib77","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood-2002-10-3064","article-title":"Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective children's cancer group study of 252 patients with acute myeloid leukemia","volume":"101","author":"Sievers","year":"2003","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.cll.2007.05.006_bib78","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/jnci\/88.20.1483","article-title":"Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry","volume":"88","author":"Sievers","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.cll.2007.05.006_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.20037","article-title":"Immunophenotypic differences between diagnosis and relapse in childhood AML: implications for MRD monitoring","volume":"63","author":"Langebrake","year":"2005","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"10.1016\/j.cll.2007.05.006_bib80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cyto.b.20025","article-title":"Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings","volume":"62","author":"Voskova","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"issue":"11","key":"10.1016\/j.cll.2007.05.006_bib81","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood.V97.11.3574","article-title":"High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)","volume":"97","author":"Baer","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2007.05.006_bib82","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cncr.21665","article-title":"Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia","volume":"106","author":"Bacher","year":"2006","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.cll.2007.05.006_bib83","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1200\/JCO.2005.05.4312","article-title":"Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group","volume":"24","author":"Langebrake","year":"2006","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.cll.2007.05.006_bib84","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1158\/1078-0432.CCR-04-1973","article-title":"Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosis","volume":"11","author":"van Stijn","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.cll.2007.05.006_bib85","first-page":"528","article-title":"Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemia","volume":"89","author":"Kern","year":"2004","journal-title":"Haematologica"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271207000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271207000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:28:04Z","timestamp":1708129684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271207000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0272271207000510"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2007.05.006","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}